Piper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $70
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $70.
Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $70.